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Objective: The objective was to explore patient characteristics and 10-year outcome of sick leave and work
disability for patients with recent-onset multiple medically unexplained symptoms (MUS) and persistent
somatoform disorders (SD).
Method: Consecutive patients consulting their family physician (FP) completed a preconsultation questionnaire
on symptoms andmental illness (n=1785). The main problemwas categorized by the FP after the consultation,
and a stratiﬁed subsample was examined using a standardized diagnostic interview (n=701). Patients
were grouped into three cohorts: recent onset of multiple MUS (n=84); Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition, persistent SD (n=183); and reference group with well-deﬁned physical disease
according to FP (n=833). Register data on sick leave and disability pension were obtained.
Results: At index consultation, disability pension was received by 8.3% (n=7) in the recent-onset multiple MUS
group, 19.1% (n=35) in the SD group and 3.5% (n=29) in the reference group. Both the recent-onset multiple
MUS group [hazard ratio (HR)=2.28, 95% conﬁdence interval (CI): 1.14–4.55] and the SD group (HR=3.26,
95% CI:1.93–5.51) had increased risk of new disability pension awards. Furthermore, the SD group had increased
risk of sick leave.
Conclusions: Both recent-onset and persistent MUS have signiﬁcant long-term impact on patient functioning in
regard to working life; this calls for early recognition and adequate management of MUS in primary care.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Symptoms that are not attributable to any conventionally deﬁned dis-
ease or disorder, also referred to as medically unexplained symptoms
(MUS) or functional symptoms, are amain problem in 15%–20% of all pri-
mary care consultations [1]. MUS represent a spectrum of severity [2–4],sentative in the International
mily Doctors and a member of
ICD-10 Mental and Behavioral
red for the other authors.
al Practice, Aarhus University,
6 78 97; fax: +45 86 12 47 88.
sendal@feap.dk (M. Rosendal),
a.oernboel@aarhus.rm.dk
. This is an open access article underranging from mild self-limiting symptoms to severe disorders that are
characterized by multiple MUS, disability and high health care use [5–8].
The present classiﬁcations of MUS appear inadequate for early rec-
ognition and satisfactory patient management [9,10]. In the Diagnostic
and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV), and
the psychiatric chapters of the International Statistical Classiﬁcation of
Diseases and Related Health Problems, 10th Revision (ICD-10), MUS
are classiﬁed as somatoform disorders [11,12]. Besides, MUS may be
classiﬁed as various functional somatic syndromes according to the
nonpsychiatric chapters of the ICD-10 [12]. The diagnostic criteria for
somatoform disorders are based on number of symptoms, number of
organ systems involved, disability severity and symptom duration of
at least 6 months. Due to the required symptom duration, the diagnosis
of somatoform disorder does not capture the vast majority of patients
withmild ormoderate conditions seen in primary care [4,13]. According
to the International Classiﬁcation of Primary Care, MUS which are notthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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by single descriptive and nonconclusive symptom codes (e.g., fatigue
or headache) [14], which capture symptoms that are expected to be
self-limiting, symptoms that need further examination and persistent
symptoms that do not fulﬁll the criteria for a speciﬁc diagnosis [13].
It has been hypothesized that early recognition of patientswithMUS
may prevent iatrogenic harmand development of chronic disorders, but
so far, mild-to-moderate conditions of MUS have been a neglected area
of research. Consequently, we know little about the clinical features of
these patients and the importance of the condition in, e.g., prognosis.
A small but growing body of research has found thatMUS are associated
with sick leave and disability pension. Severe MUS, as measured by the
Patient Health Questionnaire, had a prevalence of 15% in a population of
Dutch sick-listed employees and was associated with longer duration
of sick leave and continued work disability after 2 years [15,16].
In Denmark, 8% of all new disability pensions are awarded due to
somatoform disorders and functional syndromes [17]. Thus, more
severe conditions of MUS seem to cause considerable sick leave and
work disability, whereas little is known about the milder conditions.
A Norwegian study did, however, ﬁnd musculoskeletal complaints to
account for 30% of sick leave [18]. Likewise,moderateMUS, asmeasured
by self-reported questionnaires, have been associated with high
frequency and long duration of sick leave spells [19].
In this study,we aimed to examine the clinical importanceof earlyMUS.
We chose a categorical rather than a dimensional approach, and we
adopted a proposal for a new symptomdiagnosis ofmultipleMUSof recent
onset [10]. Patientswith recent-onsetmultipleMUSweredeﬁned in the fol-
lowing way: (1) the patient must have had at least three physical symp-
toms, simultaneously or independently of one another, within the past 6
months; (2) the presented symptoms must not be attributable to a veriﬁ-
able disease; and (3) symptom duration must be of less than 6 months.
Only signiﬁcant symptoms were considered, i.e., symptoms that had
prompted health care seeking or signiﬁcantly interfered with daily func-
tioning. The speciﬁc aims of the study were to explore sociodemographic
and clinical characteristics of patients with multiple MUS of recent onset
and persistent somatoform disorder and to explore their long-term out-
come in regard to sick leave and work disability. Outcomes for patients
with multiple MUS and persistent somatoform disorder were compared
to outcomes for patients with well-deﬁned physical disease.
2. Material and methods
2.1. Study design
This study is a 10-year register-based follow-up study of a cohort
of patients consulting their family physician (FP) for a new health
problem. The cohort was established in 2000 in the “Functional Illness
in Primary Care study” (FIP study) [8]. The FIP studywas an intervention
study on the effect of an educational program for training FPs in the
recognition and management of patients with MUS [20]. The study
was carried out in a two-phase design comprising a patient screening
questionnaire and a standardized psychiatric interview.
2.2. Participants and setting
Thirty-eight FPs participated in the FIP study. The FPs enrolled a total
of 1785 consecutive patients aged 18–65 years of Scandinavian origin
who consulted their FP for a new health problem during a 3-week peri-
od. Patients whowere too ill or demented to participate, who consulted
only for health checks or scheduled follow-up visits, or who were not
enlisted with the participating FPs were excluded from the study [8].
2.3. Patient questionnaire
In the ﬁrst phase of the study, patients completed a screening ques-
tionnaire in the FP’s waiting room just before entering the consultation.This questionnaire included an eight-item version of the Symptom Check
List (SCL-8) assessing anxiety anddepression [21,22]; the somatization sub-
scale of the SCL-90 (SCL-SOM) screening for 12 common physical symp-
toms [23]; the Whitely Index (Whitely-7) assessing illness worry and
conviction [24]; and the four-item Cutting down, Annoyance by criticism,
Guilty feeling, Eye openers (CAGE) screening questionnaire on alcohol
abuse [25]. Additionally, patients completed the Medical Outcome Study’s
Short Form Health Survey (SF-36) assessing physical and mental health
[26], and sociodemographic data were obtained. Patients with a high
score on the screening questionnaire were identiﬁed for the second phase
of the study. Except for the CAGE, which was rated “yes” or “no,” all other
scales in the screening questionnaire comprised response categories on a
5-point Likert scale, whichwas dichotomized between “a little” and ”mod-
erately”bothered.Ahigh scorewasdeﬁnedas adichotomized sumscoreon
SCL-SOM N3, Whiteley-7 N1, SCL-8 N1 or CAGE N1 [8]. The validity of the
screening questionnaire in the primary care setting has been extensively
described elsewhere [27].
2.4. Standardized psychiatric interview
In the second phase of the FIP study, a stratiﬁed sample consisting of
one in every nine of the included patients and all patients with a high
score on the screening questionnaire was selected for a standardized
psychiatric interview. A total of 701 patients (78.4%) agreed to partici-
pate. Patients with low scores on the screening questionnaire, younger
patients and males were more likely to reject participation than other
patients [8]. The psychiatric interview was carried out as soon as possi-
ble after the index consultation. The interview was based on the Sched-
ules for Clinical Assessment in Neuropsychiatry (SCAN), version 2.1.
[28]. The SCAN is endorsed by the World Health Organization (WHO)
and is a standardized, semistructured, comprehensive interview
covering all types of mental disorders, including a separate section
on screening for a wide range of physical symptoms. The interviews
were performed by six psychiatric physicians certiﬁed at the
Copenhagen WHO Scan Training Centre. An analysis of a subsample of
the SCAN interviews rated by all six interviewers showed high
interrater reliability (kappa=0.86) [8].
2.5. FP assessment
Immediately after the index consultation, the FP completed a question-
naire inquiring on the patient’s main problem, duration of main problem
and the presence of chronic physical diseases and psychiatric disorders.
The FPs categorized the patient’s main problem as: “Well-deﬁned physical
disease” (n=1009), “Probably well-deﬁned physical disease” (n=395),
“Medically unexplained symptoms” (n=229),”Psychiatric disorder with
physical manifestations” (n=95) or “No physical health complaints”
(n=39). FP rating of main problemwas missing for 18 patients.
2.6. Patient grouping
Based on the standardized psychiatric interview and the FP ratings of
each patient’s main problem, we generated three groups comprising:
(a) patients meeting the criteria for a persistent somatoform disorder
(n=183), (b) patients meeting the criteria for recent-onset multiple MUS
(n=84) and (c) patients with well-deﬁned physical disease according to
their FP (n=833).
Only SCAN-interviewed patients were included in the ﬁrst two
groups. Somatoform disorders meeting the DSM-IV requirements of
at least 6 months’ duration and clinically signiﬁcant distress or impair-
ment were diagnosed; both acute pain disorder and somatoform disor-
der not otherwise speciﬁed were excluded [11].
Of the 1009 patients who were registered with a main problem
of well-deﬁned physical disease according to their FP, 296 were SCAN-
interviewed; 54 patients met the criteria for persistent somatoform
disorders, and 35 met the criteria for recent-onset multiple MUS. To
Consecutive patients attending their 
FP for a new health problem (n=2197)
Declined (n=274)
Other reasons (n=138)
1) Patients completed screening questionnaire before the consultation (n=1785)
2) FP rated patient’s main problem after the consultation (n=1785)
-     Well-defined physical disease (n=1009)
-     Other main problem (n=776)
Random sample (1/9 of low scorers) (n=119)
- Well-defined physical disease (n=78)
- Other main problem (n=41)
Stratified sample for SCAN interview (n=894)
- Well-defined physical disease (n=383)
- Other main problem (n=511)
Declined SCAN interview (n=193)
- Well-defined physical disease (n=87)
- Other main problem (n=106)
Other main problem (n=265) No well-defined physical disease and no multiple
MUS/somatoform disorder (n=227)
Recent-onset multiple MUS (n=84)
- Well-defined physical disease (n=35)
- Other main problem (n=49)
Well-defined physical diseasea (n=833)
- No SCAN interview (n=626)
- SCAN interview (n=207)
Somatoform disorders (n=183) 
- Well-defined physical disease (n=54)
- Other main problem (n=129)
SCAN interview (n=701)
- Well-defined physical disease (n=296)
- Other main problem (n=405)
No SCAN interview (n=891) 
- Well-defined physical disease (n=626)
- Other main problem (n=265) 
High score on screening questionnaire (n=775)
-     Well-defined physical disease (n=305)
-     Other main problem (n=470)
Low score on screening questionnaire (n=1010)
-     Well-defined physical disease (n=704)
-     Other main problem (n=306)
Fig. 1. Flowchart. aFPs stated a well-deﬁned physical disease as the main problem for a total of 1009 patients; 296 of these were SCAN-interviewed, of which 35 fulﬁlled the criteria for
multiple symptoms and 54 the criteria for a persistent somatoform disorder and were classiﬁed as such.
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category of either “persistent somatoform disorders” or “recent-onset
multiple MUS” instead of the well-deﬁned physical disease group (Fig. 1).
Patients were excluded (n=685) if they refused to complete the
SCAN interview, did not fulﬁll the criteria for persistent somatoform
disorder or recent-onset multiple MUS, or had a main problem that
could not be rated aswell-deﬁned physical disease according to their FP.
2.7. Sick leave and work disability
Information on sick leave and work disability was obtained from
the Danish Register for Evaluation of Marginalization (DREAM) [29].
DREAM includes information on all Danish citizens who have
received social beneﬁts or any other welfare payment since July 1991.
Unregistered persons have not been entitled to receive any social
welfare beneﬁts since the establishment of the database. The social trans-
fers recorded in DREAM can be grouped into ﬁve categories: beneﬁts
awarded to otherwise self-supporting individuals (e.g., statutorymaterni-
ty pay), beneﬁts related to the labor market (e.g., unemployment beneﬁtor social assistance), temporary health-related beneﬁts (sickness beneﬁt
and vocational rehabilitation beneﬁt), permanent health-related beneﬁts
(full and partial disability pension) and public (old age or early) retire-
ment pension. Death and emigration of registered individuals have also
been recorded.
In general, sickness beneﬁt can be granted for a maximum of
12 months in Denmark. After this period, the individual must return
to work, may be eligible for social assistance ormay be awarded disabil-
ity pension by the municipal authorities. Individuals aged 18–65 years
with permanently reduced work ability are eligible for disability pen-
sion. Partial disability pension is granted to individuals suffering from
partial loss of working capacity on a permanent basis and “ﬂexible
working”may be arranged, while full disability pension is a permanent
departure from the labor market [30].
As a measure of sick leave and work disability, data on temporary
and permanent health-related beneﬁts were retrieved from DREAM
for a period of 10 years from the index consultation for the three patient
groups. Due to the registration procedure in DREAM, health-related
beneﬁts were recorded in weeks.
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Descriptive statisticswere used to summarize patient characteristics
at index consultation. The SF-36 Physical Component Scale and the
Mental Component Scale were transformed into scales ranging from 0
to 100 by the following expression: (patient raw score−lowest possible
score)/(highest possible score−lowest possible score)×100. Higher
scores express better health [31]. Differences in the distribution of
patient characteristics across the three patient groups were tested by
one-way analysis of variance (ANOVA) for data following a normal dis-
tribution, Kruskal–Wallis test for ordered but not normally distributed
data and χ2 test for categorical data. If statistically signiﬁcant differ-
ences were observed, post hoc pairwise comparisons were performed
by independent t test, Mann–Whitney U test, χ2 test or Fisher’s Exact
Test to identify differing patient groups.
For each patient and each week in the follow-up period, three vari-
ables were recorded for patient status: temporary or permanent
health-related beneﬁts, or either of the two. Weeks of emigration, age-
related retirement or death were not included (missings). To compare
the risk of health-related beneﬁts during 6 months, 2 years and 10
years of follow-up according to patient groups, we applied a generalized
linear model (GLM) from the binomial family using log-link. Risk ratios
(RRs) were used as a measure of association. Corresponding 95% conﬁ-
dence intervals (CIs) were assessed by performing cluster-robust vari-
ance estimation to account for the expected dependency of awarded
health-related beneﬁts in different weeks for the same patient [32].
The Cox proportional hazard model was used to compare the risk of
incident award of full or partial disability pension during 10 years of
follow-up among the three patient groups. Patient age was used as
time scale and hence was appropriately adjusted for. Patients entered
the study at the time of the index consultation (delayed entry),meaning
that theywere not observed until the index consultation, and theywere
censored at the time of death, emigration or public retirement.
The proportional-hazards assumption was graphically assessed using
log–log plots.
In all regression analyses, patients with well-deﬁned physical dis-
ease constituted the reference group. Crude estimates were presented,
as were estimates adjusted for patient age, gender, chronic illness, co-
morbid major depressive episode, or anxiety disorder, and whether
the patient had consulted an FP in the control or intervention group in
the FIP study. Two-sided P values b .05were considered to be statistically
signiﬁcant, except for post hoc pairwise comparisons of the three patient
groups, where a P value b .017 was considered statistically signiﬁcant,
following a Bonferroni correction for multiple testing. Analyses were
conducted by Stata statistical software, version 11.
2.9. Ethics
Written informed consent was obtained at inclusion from all
participants in the FIP study. The follow-up study was approved by
the Danish Data Protection Agency (ref. no. 2012-41-0118). According
to the Research Ethics Committee of the Central Denmark Region, the
Danish Act on Research Ethics Review of Health Research Projects
did not apply to this study, and consequently the study did not need
approval from the committee.
3. Results
3.1. Patient group differences at study inclusion
Patient sociodemographics and clinical characteristics at index con-
sultation are shown in Table 1. The somatoform disorder group com-
prised more females and had a higher mean age than the reference
group. Full or partial disability pension was more frequent in the
somatoformdisorder group than in the reference group, aswere chronic
illness according to FPs, major depressive episode and anxiety disorder.In line with these ﬁndings, the somatoform disorder group reported
lower physical and mental health than the reference group. Compared
to the reference group, the recent-onsetmultipleMUS group comprised
more patients with major depressive episode and anxiety disorder and
also reported lower mental health, while no difference was found in re-
gard to physical health.
3.2. Sick leave and work disability
Labor market dropout during the 10-year follow-up for each
diagnostic group is displayed in Fig. 2. Dropout reasons were death, dis-
ability pension (full or partial), public retirement or emigration. No sta-
tistically signiﬁcant differences in mortality, public retirement and
emigration were found in pairwise comparisons of the patient groups
at 6 months, 2 years and 10 years of follow-up (data not shown). The
ﬁgure shows that a higher proportion of patients in both the
somatoform disorder group and the recent-onset multiple MUS group
received disability pension during the 10 years of follow-up compared
to the reference group. At index consultation, disability pension (full
or partial) was received by 19.1% (n=35) in the somatoform disorder
group, by 8.3% (n=7) in the recent-onset multiple MUS group and by
3.5% (n=29) in the reference group. At 10-year follow-up, this was
the case for 23.5% (n=43) in the somatoform disorder group, 16.7%
(n=14) in the recent-onset multiple MUS group and 6.0% (n=50) in
the reference group. It should be noted that migration between catego-
ries were evident, e.g., patients receiving disability pension (full or par-
tial) passed on to public retirement at the age of 65 years, while others
whowere available for the labor market at the index consultation were
awarded disability pension during the follow-up period.
The risk of receiving health-related beneﬁts was compared between
groups and is presented in Table 2. At all time points, patients with
somatoform disorders had a higher risk of receiving both temporary
and permanent health-related beneﬁts (RRadjusted=1.96–2.83) than pa-
tients in the reference group. However, after 10 years of follow-up, the
CI of the adjusted risk of temporary beneﬁts included 1. Patients with
recent-onset multiple MUS did not differ from patients in the reference
group as to risk of temporary health-related beneﬁts. They did, however,
have a higher risk of receiving permanent health-related beneﬁts and
health-related beneﬁts combined (RRadjusted=1.85–2.34). When adjust-
ed for covariates, this difference only reached statistical signiﬁcance after
10 years of follow-up.
To investigate differences in risk of only new awards of permanent
health-related beneﬁts between groups during the 10 years of follow-up,
Cox regression analyses were conducted (Table 3). These showed that pa-
tients with recent-onset multiple MUS [hazard ratio (HR)adjusted=2.28]
and patients with somatoform disorders (HRadjusted=3.26) were at higher
risk of being awarded full or partial disability pension than patients in the
reference group.
4. Discussion
This study suggests that MUS, both in early and more persistent
form, have signiﬁcant long-term impact on patient functioning in regard
to working life. We used two case deﬁnitions representing different
levels of the severity spectrum of MUS: DSM-IV criteria for persistent
somatoform disorders and the new criteria suggested for multiple
MUS of recent onset.
Compared to the reference group, a considerable proportion of the
patients with somatoform disorders received full or partial disability
pension at study inclusion. These patients also reported lower physical
and mental health and displayed more physical and psychiatric comor-
bidity. The group of patients with recent-onsetmultipleMUS seemed to
be somewhere in between patients with somatoform disorders and pa-
tientswithwell-deﬁned physical disease in regard to characteristics and
outcome. They resembled the reference group at study inclusion, except
Table 1
Group differences as to patient sociodemographics and clinical characteristics at index consultation
Somatoform disorder (S) Recent-onset multiple MUS (M) Reference group (R) Pairwise comparisonsc
(n=183) (n=84) (n=833) S vs. M S vs. R M vs. R
Mean (S.D.) Mean (S.D.) Mean (S.D.) ANOVA, P Two-sample t test, P
Age, mean (S.D.) 41.4 (12.3) 38.5 (11.8) 37.7 (13.1) .002 .076 b .001 .555
n (%) n (%) n (%) χ2 testd, P χ2 testd, P
Female 143 (78.1) 49 (58.3) 493 (59.2) b .001 .001 b .001 .88
Married/with a partnera 114 (68.3) 50 (64.1) 470 (65.6) .76
Vocational traininga
Unskilled 49 (30.6) 14 (18.9) 128 (19.1)
Skilled 40 (25.0) 25 (33.8) 196 (29.2)
Higher education≤4 years 36 (22.5) 18 (24.3) 176 (26.2)
Higher education N4 years 14 (8.8) 9 (12.2) 85 (12.7)
Other education 21 (13.1) 8 (10.8) 86 (12.8) .13
Labor market dropout
Available for labor market 145 (79.2) 76 (90.5) 775 (93.0)
Partial or full disability pension 35 (19.1) 7 (8.3) 29 (3.5)
Public retirement pension 3 (1.6) 1 (1.2) 29 (3.5) b .001 .074 b .001 .069
Chronic illnessa 111 (61.3) 29 (34.5) 198 (23.8) b .001 b .001 b .001 .031
Major depressive episodeb 27 (14.8) 13 (15.5) 7 (0.8) b .001 .878 b .001 b .001
Anxiety disorderb 53 (29.0) 8 (9.5) 14 (1.7) b .001 b .001 b .001 b .001
Median (Q1–Q3)e Median (Q1–Q3)e Median (Q1–Q3)e Kruskal–Wallis test, P Mann–Whitney U test, P
Physical health (SF-36) (n=921) 42.5 (32.1–50.4) 50.9 (42.8–58.3) 51.9 (46.2–55.7) b .001 b .001 b .001 .56
Mental health (SF-36)(n=921) 44.4 (34.8–51.8) 42.0 (34.6–53.7) 56.5 (51.8–59.6) b .001 .75 b .001 b .001
a Missing values: marital status (n=139), vocational training (n=195), chronic illness (n=4).
b Diagnoses ofmajor depressive episode and anxiety disorderwere generated from the SCAN interview. Patients in the reference groupwith low screening score and no SCAN interview
were considered not to suffer from any of these diagnoses.
c Level of signiﬁcance: Pb .017 (Bonferroni correction).
d χ2 test or Fisher’s Exact Test when cell count was low.
e Q1–Q3: interquartile range.
57M.T. Rask et al. / General Hospital Psychiatry 37 (2015) 53–59for lower self-reportedmental health and higher frequency of psychiat-
ric comorbidity.
4.1. Comparison with existing literature
We found persistent somatoform disorders, as deﬁned by the DSM-
IV criteria, to be associated with increased risk of sick leave and work
disability during the 10 years of follow-up. We are not aware of other
studieswith such a long follow-up period, and our studymay, therefore,
not be directly comparable to others. However, in previous prospective
follow-up studies, severeMUS in sick-listed employees have been found
to be associatedwith prolonged sick leave andpersistentwork disability
after 2 years [16], and the number of sick leave days in women with aFig. 2. Percentage of patients who left the labor market during 1high level of common symptoms (three symptoms almost every day
or ﬁve symptoms every week) has been found to exceed the number
in women with a lower level of symptoms after 1-year follow-up [33].
When comparing the recent-onset multiple MUS group with the well-
deﬁned disease group, we were able to demonstrate increased risk of
permanent (full or partial) disability pension, but not of temporary
health-related beneﬁts including sick leave.
In line with the ﬁndings in previous studies, many of the patients
with somatoform disorders had chronic illness and high psychiatric
comorbidity [34,35]. Psychiatric morbidity in general has been found
to be associated with increased sick leave, especially sickness spells of
longer duration [36,37]. Althoughmajor depressive episode and anxiety
disorder were frequent in patients with somatoform disorders and0 years of follow-up according to the three patient groups.
Table 2
Risk of health-related beneﬁts according to patient groups during 6 months, 2 years and 10 years of follow-up
RRs (95% CI)a
6-month follow-up 2-year follow-up 10-year follow-up
Crude Adjustedb Crude Adjustedb Crude Adjustedb
Temporary health-related beneﬁtsc
Reference group 1 1 1 1 1 1
Recent-onset multiple MUS 1.54 (0.66–3.59) 1.43 (0.65–3.19) 1.31 (0.64–2.65) 1.25 (0.61–2.56) 1.29 (0.85–1.95) 1.14 (0.74–1.75)
Somatoform disorder 3.95 (2.51–6.20) 2.77 (1.64–4.67) 2.54 (1.68–3.85) 1.96 (1.21–3.17) 1.69 (1.27–2.26) 1.29 (0.91–1.82)
Permanent health-related beneﬁtsd
Reference group 1 1 1 1 1 1
Recent-onset multiple MUS 2.33 (1.05–5.15) 1.71 (0.85–3.43) 2.60 (1.21–5.60) 1.82 (0.94–3.55) 3.06 (1.73–5.39) 2.34 (1.41–3.88)
Somatoform disorder 5.71 (3.62–9.01) 2.29 (1.49–3.54) 6.19 (3.98–9.62) 2.46 (1.61–3.75) 6.27 (4.37–8.99) 2.83 (1.92–4.17)
Health-related beneﬁts, combinede
Reference group 1 1 1 1 1 1
Recent-onset multiple MUS 1.94 (1.11–3.40) 1.46 (0.91–2.35) 1.93 (1.15–3.26) 1.47 (0.91–2.36) 2.19 (1.43–3.33) 1.85 (1.27–2.68)
Somatoform disorder 4.85 (3.59–6.55) 2.33 (1.70–3.18) 4.30 (3.21–5.76) 2.11 (1.57–2.83) 4.02 (3.13–5.15) 2.24 (1.71–2.94)
Figures in bold are statistically signiﬁcant.
a RRs were based on a GLM. Corresponding 95% conﬁdence intervals (95%CI) were assessed by the use of cluster-robust variance estimation.
b Adjusted for age, gender, chronic illness, major depressive episode, anxiety disorder and intervention.
c Temporary health-related beneﬁts: sickness beneﬁt and vocational rehabilitation beneﬁt.
d Permanent health-related beneﬁt: full and partial disability pension.
e Health-related beneﬁts, combined: temporary or permanent health-related beneﬁts.
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creased risk of receiving health-related beneﬁts even after adjustment
for both psychiatric and chronic medical comorbidity. Thus, anxiety
and depression did not fully explain the increased risk. These ﬁndings
correspond with previous studies in which MUS were found to predict
sick leave independently of anxiety and depression [19,35,38].
The FPs in primary care see the full spectrum of MUS, ranging from
minor complaints that do not need further attention to severe and
persistent disorders. Thus, there is a need for a classiﬁcation of MUS that
captures both mild and severe conditions [13]. In order to meet this need,
we chose a categorical rather than a dimensional approach to explore the
characteristics and outcomes of patients with MUS of recent onset versus
patients with persistent conditions of MUS. The results of the present
study indicate that even patients with MUS of recent onset are at risk of a
poor long-term outcome, and the ﬁndings support the hypothesis of a gra-
dient in severity of the investigated conditions. These results are also sup-
ported by previous studies showing that disability, frequency of sickness
spells and health care utilization tend to increase with number of MUS
and increasing levels of symptom severity [3,19,39].
As the majority of symptoms presented to the FP are self-limiting and
improve shortly after consultation [40], the category of recent-onset multi-
ple MUS may capture both symptoms that resolve and symptoms that
evolve into a clearer picture of disease or disorder. Smith et al. have previ-
ously investigated the course of “minor acute illness” deﬁned as MUS that
resolve in less than6months [41]. They found thatminor acute illness (con-
trary to somatization)was relatively stable amongpatientswith high use of
health care services; the majority of initially diagnosed patients continued
to have minor acute illness also at one- or two-year follow-up [41]. There
may be considerable overlap between our group of patients with recent-
onset multiple MUS and the minor acute illness group as deﬁned by
Smith et al. Yet, on the basis of the present study, it cannot be concluded
whether or not patients with multiple MUS of recent onset come to meetTable 3
Risk of new awards of permanent health-related beneﬁts (full and partial disability
pension) according to patient groups during 10 years of follow-up
New awards
n
HRs (95%CI)
Crude Adjusteda
Reference group 45 1 1
Recent-onset multiple MUS 10 2.15 (1.08–4.27) 2.28 (1.14–4.55)
Somatoform disorder 31 4.04 (2.55–6.40) 3.26 (1.93–5.51)
a Adjusted for age, gender, chronic illness, major depressive episode, anxiety disorder
and intervention.the criteria for persistent somatoform disorders over time and whether
the category of recent-onset multiple MUS forms part of the somatoform
spectrum. In our study, we have been able to describe a group of patients
with subthreshold conditions of MUS and unfavorable long-term outcome.
To further explore the validity of thenewconstruct of recent-onsetmultiple
MUS, future studies that address the validity criteria suggested by,
e.g., Kendell areneeded [42], inparticular longitudinal studieswithdiagnos-
tic follow-up.
4.2. Strengths and limitations
The major strengths of this study are the long follow-up period and
that no patients were lost to follow-up, except for emigrants, as out-
come data were obtained from the Danish national register DREAM,
which holds information on all Danish social beneﬁts and welfare pay-
ments. The Danish social security system is publicly provided, and the
completeness of DREAM is generally considered high as data are contin-
uously updated by state authorities. Validity studies of DREAM have
found a positive predictive value of 95% when comparing data on full
disability pension in DREAM with self-reports, while the probability of
information in DREAM being in concordance with employers’ informa-
tion on sick leave has been found to equal 96.7% [29,43]. Thus, DREAM
provides high-quality data on health-related beneﬁts.
Another major strength of the study was that the categorization of pa-
tient groups was based on standardized psychiatric diagnostic interviews.
Rather than relying on the FPs’ subjective identiﬁcation of MUS or on pa-
tient self-reported symptoms in questionnaires, symptomswere systemat-
ically screened for by trained raters and assessed as medically unexplained
according to pre-deﬁned criteria. However, only a stratiﬁed sample of 701
patients (either randomly selected or with a high score on the screening
questionnaire) was SCAN-interviewed. Therefore, some of the patients in
the medical condition group may have been undetected cases of recent-
onset multiple MUS or persistent somatoform disorders. As this potential
misclassiﬁcation would bias the observed differences towards the null,
the presented results are expected to be conservative estimates. Thus, we
have no reason to believe that misclassiﬁcations pose a particular problem
to the validity of our study conclusions.
A limitation of the study was that the patient groups were catego-
rized exclusively on the basis of baseline measures and that patient sta-
tus according to somatoform disorders, recent-onset multiple MUS and
well-deﬁned physical diseasewasnot re-assessed during the10 years of
follow-up. In former longitudinal studies of patients who meet the
criteria for somatoform disorders, 22%–53% of patients have been
found to still have a somatoform disorder at follow-up, depending on
59M.T. Rask et al. / General Hospital Psychiatry 37 (2015) 53–59the criteria applied and the investigated time interval [44–47]. The
studied conditionsmay thusﬂuctuate, andwe do not knowwhether pa-
tients with persistent somatoform disorders or recent-onset multiple
MUS met the diagnostic criteria throughout follow-up, nor do we
know whether cases of recent-onset multiple MUS developed into
more persistent conditions over time. The medical reasons for the
health-related beneﬁts are not recorded in DREAM, and we did not re-
cord new physical or psychiatric diagnoses during follow-up.
Consequently, we cannot exclude that the increased risk of receiving
temporary and permanent health-related beneﬁtsmay partly be related
to such other factors.
For employees, sick leave of 2 weeks or more is registered only in
DREAM; this implies that sick leave due to episodes of, e.g., seasonal
acute infections was excluded. However, short-term sick leave
(b2 weeks) of unemployed individuals, who are eligible for sickness
beneﬁt from the municipality, is registered irrespective of duration.
Somatoform disorder has previously been shown to be associated
with more frequent sickness spells and discharge [16,19]. Thus, RRs of
temporary health-related beneﬁts in patients with somatoform disor-
ders may be overestimated due to the patients’ employment status
and frequent short-term sickness spells.
4.3. Conclusions
This 10-year follow-up study indicates that early recognition and ade-
quatemanagement of patientswithMUSwho do notmeet the criteria for
a persistent somatoformdisorder should be a priority in primary care. The
study calls for further exploration of the prognosis of these patients with
the aim to identify risk factors for poor outcomes that may be targeted in
clinical practice. The category of recent-onsetmultipleMUSmay be a use-
ful tool for recognition and classiﬁcation of patients with subthreshold
conditions ofMUS. However, more studies are needed in this ﬁeld to con-
solidate the current ﬁndings and further explore the clinical validity and
usefulness of the category of recent-onset multiple MUS.
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